Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Electron Optics in Phosphorene pn Junctions: Negative Reflection and Anti-Super-Klein Tunneling.

Betancur-Ocampo Y, Leyvraz F, Stegmann T.

Nano Lett. 2019 Nov 13;19(11):7760-7769. doi: 10.1021/acs.nanolett.9b02720. Epub 2019 Oct 15.

PMID:
31544466
2.

On the importance of the innervation of the human cervical longitudinal ligaments at vertebral level.

Stegmann T, Steinke H, Pieroh P, Dehghani F, Völker A, Groll MJ, Wolfskämpf T, Werner M, Kollan J, Hinz A, Leimert M.

Surg Radiol Anat. 2020 Feb;42(2):127-136. doi: 10.1007/s00276-019-02316-6. Epub 2019 Sep 6.

PMID:
31493007
3.

[Embolic stroke of undetermined source (ESUS) : How much monitoring is necessary?]

Stegmann T, Wachter R, Schäbitz WR.

Herz. 2019 Jun;44(4):289-295. doi: 10.1007/s00059-019-4805-8. German.

PMID:
31062047
4.

Robustness of optimal transport in disordered interacting many-body networks.

Ortega A, Stegmann T, Benet L.

Phys Rev E. 2018 Jul;98(1-1):012141. doi: 10.1103/PhysRevE.98.012141.

PMID:
30110776
5.

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability.

Lederhofer J, van Lent J, Bhoelan F, Karneva Z, de Haan A, Wilschut JC, Stegmann T.

Pharm Res. 2018 Jul 3;35(9):172. doi: 10.1007/s11095-018-2453-y.

6.

Affinity of human IgG subclasses to mouse Fc gamma receptors.

Dekkers G, Bentlage AEH, Stegmann TC, Howie HL, Lissenberg-Thunnissen S, Zimring J, Rispens T, Vidarsson G.

MAbs. 2017 Jul;9(5):767-773. doi: 10.1080/19420862.2017.1323159. Epub 2017 May 2.

7.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

PMID:
28082442
8.

Efficient quantum transport in disordered interacting many-body networks.

Ortega A, Stegmann T, Benet L.

Phys Rev E. 2016 Oct;94(4-1):042102. Epub 2016 Oct 3.

PMID:
27841460
9.

Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti-immunoglobulin reagent.

Howie HL, Delaney M, Wang X, Er LS, Vidarsson G, Stegmann TC, Kapp L, Lebedev JN, Wu Y, AuBuchon JP, Zimring JC.

Transfusion. 2016 Dec;56(12):2953-2962. doi: 10.1111/trf.13812. Epub 2016 Sep 16.

10.

Identification of a novel frequent RHCE*ce308T variant allele in Chinese D- individuals, resulting in a C+c- phenotype.

Stegmann TC, Ji Y, Bijman R, Wang Z, Wen J, Wei L, Veldhuisen B, Haer-Wigman L, Lighthart P, Lodén-van Straaten M, Luo G, van der Schoot CE.

Transfusion. 2016 Sep;56(9):2314-21. doi: 10.1111/trf.13709. Epub 2016 Jun 24.

PMID:
27338008
11.

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.

Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE.

Br J Haematol. 2016 May;173(3):469-79. doi: 10.1111/bjh.13960. Epub 2016 Mar 27.

PMID:
27018217
12.

Impact of genetic variation in the SMIM1 gene on Vel expression levels.

Haer-Wigman L, Stegmann TC, Solati S, Ait Soussan A, Beckers E, van der Harst P, van Hulst-Sundermeijer M, Ligthart P, van Rhenen D, Schepers H, de Haas M, van der Schoot CE.

Transfusion. 2015 Jun;55(6 Pt 2):1457-66. doi: 10.1111/trf.13014. Epub 2015 Feb 3.

PMID:
25647324
13.

Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice.

Kourtis IC, Hirosue S, de Titta A, Kontos S, Stegmann T, Hubbell JA, Swartz MA.

PLoS One. 2013 Apr 23;8(4):e61646. doi: 10.1371/journal.pone.0061646. Print 2013.

14.

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats.

Kamphuis T, Stegmann T, Meijerhof T, Wilschut J, de Haan A.

Influenza Other Respir Viruses. 2013 Nov;7(6):1227-36. doi: 10.1111/irv.12112. Epub 2013 Apr 10.

15.

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats.

Kamphuis T, Shafique M, Meijerhof T, Stegmann T, Wilschut J, de Haan A.

Vaccine. 2013 Apr 19;31(17):2169-76. doi: 10.1016/j.vaccine.2013.02.043. Epub 2013 Mar 13.

PMID:
23499594
16.

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice.

Kamphuis T, Meijerhof T, Stegmann T, Lederhofer J, Wilschut J, de Haan A.

PLoS One. 2012;7(5):e36812. doi: 10.1371/journal.pone.0036812. Epub 2012 May 9.

17.

Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulation.

Stegmann T, Kamphuis T, Meijerhof T, Goud E, de Haan A, Wilschut J.

Vaccine. 2010 Aug 2;28(34):5543-50. doi: 10.1016/j.vaccine.2010.06.041. Epub 2010 Jun 25.

PMID:
20600502
18.

Comparison of closure of gastric perforation ulcers with biodegradable lactide-glycolide-caprolactone or omental patches.

Bertleff MJ, Stegmann T, Liem RS, Kors G, Robinson PH, Nicolai JP, Lange JF.

JSLS. 2009 Oct-Dec;13(4):550-4. doi: 10.4293/108680809X12589998404362.

19.
20.

Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying.

Amorij JP, Meulenaar J, Hinrichs WL, Stegmann T, Huckriede A, Coenen F, Frijlink HW.

Vaccine. 2007 Aug 29;25(35):6447-57. Epub 2007 Jul 16.

PMID:
17673338
21.

Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes.

de Jonge J, Schoen P, ter Veer W, Stegmann T, Wilschut J, Huckriede A.

Biochim Biophys Acta. 2006 Apr;1758(4):527-36. Epub 2006 Apr 3.

22.

The virosome concept for influenza vaccines.

Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, Wilschut J.

Vaccine. 2005 Jul 8;23 Suppl 1:S26-38. Review.

PMID:
16026906
23.

FGF-1: a human growth factor in the induction of neoangiogenesis.

Stegmann TJ.

Expert Opin Investig Drugs. 1998 Dec;7(12):2011-5.

PMID:
15991943
24.

Pore formation in target liposomes by viral fusion proteins.

Bonnafous P, Stegmann T.

Methods Enzymol. 2003;372:408-18. No abstract available.

PMID:
14610827
25.

Functional reconstitution of the HIV receptors CCR5 and CD4 in liposomes.

Devesa F, Chams V, Dinadayala P, Stella A, Ragas A, Auboiroux H, Stegmann T, Poquet Y.

Eur J Biochem. 2002 Nov;269(21):5163-74.

26.

Spontaneous lipid vesicle fusion with electropermeabilized cells.

Ramos C, Bonato D, Winterhalter M, Stegmann T, Teissié J.

FEBS Lett. 2002 May 8;518(1-3):135-8.

27.

Fusion of human neutrophil phagosomes with lysosomes in vitro: involvement of tyrosine kinases of the Src family and inhibition by mycobacteria.

Peyron P, Maridonneau-Parini I, Stegmann T.

J Biol Chem. 2001 Sep 21;276(38):35512-7. Epub 2001 Jul 19.

29.

Combined Local Angiogenesis and Surgical Revascularization for Coronary Artery Disease.

Stegmann TJ, Hoppert T.

Curr Interv Cardiol Rep. 1999 Jul;1(2):172-178. No abstract available.

PMID:
11096622
30.

[Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease].

Stegmann TJ, Hoppert T, Schneider A, Gemeinhardt S, Köcher M, Ibing R, Strupp G.

Herz. 2000 Sep;25(6):589-99. Review. German.

PMID:
11076317
31.

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK.

Circulation. 2000 Sep 12;102(11):E73-86. Review.

PMID:
10982554
33.

Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.

Günther-Ausborn S, Schoen P, Bartoldus I, Wilschut J, Stegmann T.

J Virol. 2000 Mar;74(6):2714-20.

34.

[Papillary muscle rupture during stress ECG after myocardial infarct].

Hanke T, Raschka C, Strupp G, Schreiner G, Günther HU, Stegmann T, Bonzel T.

Z Kardiol. 1999 Mar;88(3):225-8. German.

PMID:
10355073
36.

The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results.

Schumacher B, Stegmann T, Pecher P.

J Cardiovasc Surg (Torino). 1998 Dec;39(6):783-9.

PMID:
9972900
37.
38.

Pores formed by influenza hemagglutinin.

Jiricek R, Schwarz G, Stegmann T.

Biochim Biophys Acta. 1997 Nov 13;1330(1):17-28.

39.
40.
41.

Kinetics of fusion between endoplasmic reticulum vesicles in vitro.

Orsel JG, Bartoldus I, Stegmann T.

J Biol Chem. 1997 Feb 7;272(6):3369-75.

42.

False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I autoantibodies.

Bohner J, von Pape KW, Hannes W, Stegmann T.

Clin Chem. 1996 Dec;42(12):2046. No abstract available.

PMID:
8969651
43.

Membrane asymmetry is maintained during influenza-induced fusion.

Klotz KH, Bartoldus I, Stegmann T.

J Biol Chem. 1996 Feb 2;271(5):2383-6.

44.

Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine.

Günther-Ausborn S, Praetor A, Stegmann T.

J Biol Chem. 1995 Dec 8;270(49):29279-85.

45.

Evaluation of cytomegalovirus-polymerase chain reaction in graft dysfunction after heart transplantation.

König L, Schumacher B, Pecher P, Keilich M, Günther HU, Straeten G, Stegmann T.

Transplant Proc. 1995 Jun;27(3):1963-6. No abstract available.

PMID:
7792852
46.

Calorimetric detection of influenza virus induced membrane fusion.

Nebel S, Bartoldus I, Stegmann T.

Biochemistry. 1995 May 2;34(17):5705-11.

PMID:
7727430
47.

Limitations of the octadecylrhodamine dequenching assay for membrane fusion.

Stegmann T, Orsel JG, Jamieson JD, Padfield PJ.

Biochem J. 1995 May 1;307 ( Pt 3):875-6; author reply 876-8. No abstract available.

48.

Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1.

Frey S, Marsh M, Günther S, Pelchen-Matthews A, Stephens P, Ortlepp S, Stegmann T.

J Virol. 1995 Mar;69(3):1462-72.

49.

Influenza hemagglutinin-mediated membrane fusion: influence of receptor binding on the lag phase preceding fusion.

Stegmann T, Bartoldus I, Zumbrunn J.

Biochemistry. 1995 Feb 14;34(6):1825-32.

PMID:
7849043
50.

[Emergency bypass operation after failed elective percutaneous transluminal coronary angioplasty].

Schumacher B, Pecher P, Keilich M, Günther HU, Stegmann T.

Helv Chir Acta. 1994 Dec;60(6):1137-42. German.

PMID:
7875995

Supplemental Content

Loading ...
Support Center